Gene · 5817
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pinpointing potent hits for cancer immunotherapy targeting the TIGIT/PVR pathway using the XGBoost model, centroid-based virtual screening, and MD simulation. | Comput Biol Chem | 2025 | 40194343 | PubTator, text mining | PubMed |
| Expression Patterns of Immune Checkpoint Molecules and Their Clinical Values in Gastric Neuroendocrine Neoplasms. | Clin Transl Gastroenterol | 2025 | 40183457 | PubTator, text mining | PubMed |
| VPS25 Promotes an Immunosuppressive Microenvironment in Head and Neck Squamous Cell Carcinoma. | Biomolecules | 2025 | 40149859 | PubTator, text mining | PubMed |
| Unusual traits shape the architecture of the Ig ancestor molecule. | Commun Biol | 2025 | 40113983 | PubTator, text mining | PubMed |
| TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environment. | J Clin Invest | 2025 | 40111422 | PubTator, text mining | PubMed |
| Aspartate beta-hydroxylase is a prognostic factor in gallbladder cancer with the function of promoting tumorigenesis and chemoresistance. | Front Endocrinol (Lausanne) | 2025 | 40110547 | PubTator, text mining | PubMed |
| Cell membrane-derived nanovesicles as extracellular vesicle-mimetics in wound healing. | Mater Today Bio | 2025 | 40104636 | PubTator, text mining | PubMed |
| Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers. | Mol Cancer | 2025 | 40087745 | PubTator, text mining | PubMed |
| TIGIT/PVR axis regulates anti-tumor immunity in hematologic malignancies. | Ann Hematol | 2025 | 40074838 | PubTator, text mining | PubMed |
| PVR exposure influences the activation, adhesion, and protein expression of human CD8+ T cells, including the CD96-mediated transfer of PVR. | J Immunol | 2025 | 40073261 | PubTator, text mining | PubMed |
| Plac1+ Tumor Cell-Treg Interplay Supports Tumorigenesis and Progression of Head and Neck Cancer. | Adv Sci (Weinh) | 2025 | 40056047 | PubTator, text mining | PubMed |
| Effects of c-Kit Receptor, AKT, and NF-κB Inhibitors on Immune Evasion in Multiple Myeloma Cells. | Iran J Allergy Asthma Immunol | 2025 | 40052893 | PubTator, text mining | PubMed |
| Preclinical application of a CD155 targeting chimeric antigen receptor T cell therapy for digestive system cancers. | Oncogene | 2025 | 40025231 | PubTator, text mining | PubMed |
| [Expression and Clinical Significance of Co-inhibitory Molecules TIGIT/CD155 and PD-1 in Chronic Lymphocytic Leukemia]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 40017186 | PubTator, text mining | PubMed |
| Current Blood Eosinophilia Does Not Predict the Presence of Pulmonary Hypertension in Patients with End-Stage Lung Disease. | J Clin Med | 2025 | 40004650 | PubTator, text mining | PubMed |
| Blebbisomes are large, organelle-rich extracellular vesicles with cell-like properties. | Nat Cell Biol | 2025 | 39984653 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals the multidimensional dynamic heterogeneity from primary to metastatic gastric cancer. | iScience | 2025 | 39967875 | PubTator, text mining | PubMed |
| Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn's disease patients. | Int J Immunopathol Pharmacol | 2025 | 39959979 | PubTator, text mining | PubMed |
| Establishment of a Panel of Human Cell Lines to Identify Cellular Receptors Used by Enteroviruses to Infect Cells. | Int J Mol Sci | 2025 | 39940693 | PubTator, text mining | PubMed |
| Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms. | Nat Commun | 2025 | 39915477 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5817/papers?page=17